Docetaxel Injection
Product Description
Seacross Pharmaceuticals Ltd
-
GB -
2021On CPHI since
-
1Certificates
-
1 - 24Employees
Company types
Primary activities
Categories
Specifications
Seacross Pharmaceuticals Ltd
-
GB
-
2021On CPHI since
-
1Certificates
-
1 - 24Employees
Company types
Primary activities
More Products from Seacross Pharmaceuticals Ltd (2)
-
Product Azacitidine for injection
Indication:Oncology
Modality:Small molecule
-
Product Bendamustine hydrochloride for injection
Indication:Oncology
Modality:Small molecule
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance